National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

STATUTORY RULES

1971 No.

_________

 

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1970.*

WHEREAS it is provided by sub-section (4.) of section 101 of the National Health Act 1953-1970 that a drug or medicinal preparation that was not a pharmaceutical benefit under the National Health Act 1953-1958 immediately before the commencement of that sub-section shall not be prescribed as a pharmaceutical benefit in accordance with section 85 of that Act unless the Pharmaceutical Benefits Advisory Committee has recommended to the Minister that it be so prescribed:

AND WHEREAS that Committee has recommended to the Minister that the following additional drugs and medicinal preparations be prescribed as pharmaceutical benefits under section 85 of the National Health Act 1953-1970, namely, the drugs and medicinal preparations specified in the Third Schedule to the National Health (Pharmaceutical Benefits) Regulations, as amended by the following Regulations, that had not previously been prescribed as pharmaceutical benefits:

NOW THEREFORE I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1970.

Dated this twenty ninth day of July, 1971.

Paul Hasluck

Governor-General.

By His Excellency’s Command,

Minister of State for Health.

___________

 

Amendments of the National Health (Pharmaceutical Benefits) Regulations 

Commencement.

1. These Regulations shall come into operation on the first day of August, 1971.

First, Second, Third, Fourth and Fifth Schedules.

2. The First, Second, Third, Fourth and Fifth Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules inserted in their stead:—

FIRST SCHEDULE Regulation 10.

Drugs and Medicinal Preparations in the British Pharmacopoeia that are not to be supplied as or, except as specially provided, used in pharmaceutical benefits

1. Acetomenaphthone	8. Almond Oil
2. Acetomenaphthone Tablets	9. Aluminium Hydroxide Tablets
3. Acetrizoic Acid	10. Amethocaine Hydrochloride
4. Alcohol Dehydrated	11. Amitriptyline Injection
5. Alcohol (95%)	12. Amodiaquine Tablets
6. Allopurinol	13. Amphetamine Sulphate
7. Aloes	14. Amphetamine Sulphate Tablets

* Notified in the Commonwealth Gazette on  1971.

  Statutory Rules 1960, No. 17, as amended to date. For previous amendments of the Public Service Regulations see footnote   to Statutory Rules 1971, No. 44, and see also Statutory Rules 1971, No. 44.

16880/71—Price 30c 10/14.7.1970

First Schedule—continued

15. Amylobarbitone Sodium Tablets	81. Cholera Vaccine Mixed
16. Antazoline Hydrochloride	82. Choline Theophyllinate Tablets
17. Antazoline Tablets	83. Cinchocaine Hydrochloride
18. Antimony Sodium Tartrate	84. Cinnamon
19. Antimony Sodium Tartrate Injection	85. Clofibrate
20. Apomorphine Hydrochloride	86. Cochineal
21. Apomorphine Injection	87. Colchicine
22. Arachis Oil	88. Colchicum Corm
23. Aspirin Phenacetin and Codeine	89. Colchicum Liquid Extract
Tablets	90. Colchicum Tincture
24. Aspirin Phenacetin and Codeine	91. Colistin Tablets
Tablets Soluble	92. Colophony
25. Azathioprine	93. Concentrated Peppermint Water
26. Bacillus Calmette-Guérin Vaccine	94. Coriander
27. Barium Sulphate	95. Coriander Oil
28. Beclomethasone Dipropionate	96. Corticotrophin
29. Belladonna Herb	97. Cottonseed Oil
30. Belladonna Herb, Powdered	98. Corticotrophin Injection
31. Bemegride	99. Corticotrophin Gelatin Injection
32. Bendrofluazide	100. Corticotrophin Zinc Hydroxide Injection
33. Bemegride Injection	101. Cresol and Soap Solution
34. Benzhexol Hydrochloride	102. Cresol
35. Benzyl Alcohol	103. Crotamiton
36. Betamethasone Sodium Phosphate Tablets	104. Cyanocobalamin
37. Bethanidine Sulphate	105. Cyanocobalamin (57 Co)
38. Bisacodyl	106. Cyanocobalamin (54 Co)
39. Bisacodyl Suppositories	107. Cyclamic Acid
40. Bisacodyl Tablets	108. Cyclizine Tablets
41. Botulinum Antitoxin	109. Cyclobarbitone Calcium
42. Bupivacaine Hydrochloride	110. Cyclomethycaine Sulphate
43. Busulphan	111. Cyclopenthiazide
44. Butobarbitone	112. Cyclopentolate Hydrochloride
45. Butylated Hydroxyanisole	113. Cyclopropane
46. Butylated Hydroxytoluene	114. Cycloserine
47. Caffeine Hydrate	115. Dapsone
48. Calciferol Solution	116. Dequalinium Acetate
49. Calcium Cyclamate	117. Dequalinium Chloride
50. Camphor	118. Desipramine Hydrochloride
51. Caramiphen Hydrochloride	119. Dexamphetamine Sulphate
52. Caramiphen Tablets	120. Dexamphetamine Tablets
53. Caraway	121. Dextran 110 Injection
54. Carbimazole	122. Dextromethorphan Hydrobromide
55. Carbon Dioxide	123. Dextromethorphan Tablets
56. Carbromal	124. Dextropropoxyphene Capsules
57. Carbromal Tablets	125. Dextropropoxyphene Hydrochloride
58. Cardamom Fruit	126. Dextropropoxyphene Napsylate
59. Cascara	127. Dextrose Monohydrate
60. Catgut, Sterilised, Surgical	128. Diamorphine Hydrochloride
61. Cellulose, Oxidised	129. Diamorphine Injection
62. Cetylpyridinium Chloride	130. Diazepam Capsules
63. Chlorambucil	131. Dibromopropamidine Isethionate
64. Chlordiazepoxide Capsules	132. Dichloralphenazone
65. Chlordiazepoxide Hydrochloride	133. Dichlorophen
66. Chlorhexidine Gluconate Solution	134. Dichlorphenamide
67. Chloroform	135. Diethylcarbamazine Citrate
68. Chlormadinone Acetate	136. Diethylcarbamazine Tablets
69. Chloroquine Phosphate	137. Digitalis Leaf
70. Chloroquine Phosphate Injection	138. Digitalis Prepared
71. Chloroquine Sulphate	139. Digitoxin
72. Chlorothiazide	140. Digitoxin Tablets
73. Chlorotrianisene	141. Dihydrocodeine Injection
74. Chlorotrianisene Capsules	142. Dihydrocodeine Tablets
75. Chlorphenesin	143. Diloxanide Furoate
76. Chlorproguanil Hydrochloride	144. Dilute Alcohols
77. Chlorproguanil Tablets	145. Dimenhydrinate
78. Chlorpropamide	146. Dimenhydrinate Injection
79. Chlortetracycline Hydrochloride	147. Dimenhydrinate Tablets
80. Chlorthalidone	148. Dimercaprol

First Schedule—continued

149. Dimethisterone	214. Hydroflumethiazide
150. Dimethisterone Tablets	215. Hydrogen Peroxide Solution, Strong
151. Diodone Injection	216. Hydroxocobalamin
152. Diphtheria and Pertussis Vaccine	217. Hydroxychloroquine Sulphate
153. Diphtheria, Tetanus and Poliomyelitis	218. Hyoscine Injection
Vaccine	219. Hyoscine Eye Ointment
154. Diphtheria, Tetanus, Pertussis and	220. Hyoscine Tablets
Poliomyelitis Vaccine	221. Hyoscyamus
155. Dipipanone Hydrochloride	222. Hyoscyamus Dry Extract
156. Dipipanone Injection	223. Indigo Carmine
157. Dodecyl Gallate	224. Influenza Vaccine
158. Domiphen Bromide	225. Industrial Methylated Spirit
159. Dried Human Albumin	226. Inulin
160. Dusting Powder Absorbable	227. Inulin Injection
161. Edrophonium Chloride	228. Iodinated (181 I) Human Serum Albumin Injection
162. Eltor Vaccine	229. Iodipamide Meglumine Injection
163. Emetine and Bismuth Iodide	230. Iodised Oil Fluid Injection
164. Emetine Hydrochloride	231. Iopanoic Acid
165. Erythromycin	232. Iopanoic Acid Tablets
166. Ethacrynic Acid	233. Iophendylate Injection
167. Ethchlorvynol	234. Iothalamic Acid
168. Ether Anaesthetic	235. Ipecacuanha, Prepared
169. Ethinyloestradiol	236. Isocarboxazid
170. Ethionamide	237. Isocarboxazid Tablets
171. Ethisterone	238. Isoniazid
172. Ethopropazine Hydrochloride	239. Isopropyl Alcohol
173. Ethotoin	240. Kaolin, Heavy
174. Ethyl Chloride	241. Laevulose
175. Ethyl Oleate	242. Lemon Peel, Dried
176. Ethylenediamine Hydrate	243. Levallorphan Injection
177. Eucalyptus Oil	244. Levorphanol Tartrate
178. Ethynodiol Diacetate	245. Lignocaine and Adrenaline Injection
179. Eugenol	246. Liothyronine Sodium
180. Ferric Citrate (60 Fe) Injection	247. Liquorice
181. Ferrous Fumarate	248. Lithium Carbonate
182. Ferrous Succinate Tablets	249. Lithium Carbonate Tablets
183. Fludrocortisone Acetate	250. Lucanthone Hydrochloride
184. Fluoxymesterone	251. Lucanthone Tablets
185. Gallamine Triethiodide	252. Lynoestrenol
186. Gallamine Injection	253. Magnesium Stearate
187. Gamma Benzene Hexachloride	254. Maize Oil
188. Gelatin Sponge, Absorbable	255. Male Fern
189. Gentian	256. Male Fern Extract
190. Gentian Tincture, Compound	257. Maleic Acid
191. Ginger	258. Measles Vaccine (Inactivated)
192. Gold (193 Au) Injection	259. Measles Vaccine (Live Attenuated)
193. Halothane	260. Mecamylamine Hydrochloride
194. Helium	261. Mefenamic Acid
195. Heparin	262. Mefenamic Acid Capsules
196. Hexachlorophane	263. Megestrol Acetate
197. Hexylresorcinol	264. Meglumine Iothalamate Injection
198. Histamine Acid Phosphate	265. Melarsoprol
199. Histamine Acid Phosphate Injection	266. Melarsoprol Injection
200. Human Albumin	267. Mepacrine Hydrochloride
201. Human Blood, Whole	268. Mephentermine Sulphate
202. Human Red Blood, Corpuscles, Concentrated	269. Meprobamate
203. Human Fibrin Foam	270. Meprobamate Tablets
204. Human Fibrinogen	271. Mepyramine Injection
205. Human Normal Gamma Globulin Injection	272. Mepyramine Maleate
206. Human Plasma, Dried	273. Mepyramine Tablets
207. Human Plasma Protein Fraction	274. Mercaptopurine
208. Human Plasma Protein Fraction, Dried	275. Mersalyl Acid
209. Human Serum, Dried	276. Mestranol
210. Human Thrombin	277. Metaraminol Tartrate
211. Hydrochlorothiazide	278. Methadone Hydrochloride
212. Hydrocortisone Hydrogen Succinate	279. Methandienone
213. Hydrocortisone Sodium Succinate	280. Methicillin Sodium
281. Methohexitone Injection
282. Methoin

First Schedule—continued

283. Methoserpidine		352. Phenazocine Tablets
284. Methoserpidine Tablets		353. Phenelzine Sulphate
285. Methoxyflurane		354. Phenelzine Tablets
286. Methyl Hydroxybenzoate		355. Phenindamine Tartrate
287. Methylamphetamine Hydrochloride		356. Phenindione
288. Methylamphetamine Injection		357. Phenmetrazine Hydrochloride
289. Methylamphetamine Tablets		358. Phenmetrazine Tablets
290. Methyldopa		359. Phenolphthalein Tablets
291. Methylergometrine Maleate		360. Phenolsulphonphthalein
292. Methylprednisolone Tablets		361. Phenoxybenzamine Capsules
293. Methylthiouracil		362. Phenoxybenzamine Hydrochloride
294. Methylthiouracil Tablets		363. Phenoxymethylpenicillin
295. Methyprylone		364. Phenoxymethylpenicillin Potassium
296. Methyprylone Tablets		365. Phentolamine Mesylate
297. Metronidazole		366. Phentolamine Injection
298. Nalorphine Hydrobromide		367. Phosphoric Acid
299. Nandrolone Decanoate		368. Phytomenadione Capsules
300. Nandrolone Phenylpropionate		369. Phytomenadione Tablets
301. Naphazoline Hydrochloride		370. Piperazine Citrate
302. Nealbarbitone		371. Piperazine Phosphate Tablets
303. Nealbarbitone Tablets		372. Poldine Methylsulphate
304. Neostigmine Bromide		373. Poldine Tablets
305. Nialamide		374. Poliomyelitis Vaccine (Inactivated)
306. Nialamide Tablets		375. Poliomyelitis Vaccine (Oral)
307. Niclosamide		376. Potassium Bromide
308. Nicotinic Acid		377. Potassium Chloride Injection
309. Nicoumalone		378. Potassium Hydroxide
310. Nikethamide		379. Potassium Nitrate
311. Nikethamide Injection		380. Prednisolone Sodium Phosphate Injection
312. Nitrous Oxide		381. Prednisolone Pivalate Injection
313. Norethandrolone		382. Prednisone Acetate
314. Norethandrolone Tablets		383. Primaquine Phosphate
315. Norethisterone		384. Probenecid
316. Norethynodrel		385. Procainamide Tablets
317. Noscapine		386. Procaine and Adrenaline Injection
318. Novobiocin Calcium		387. Prochlorperazine Maleate
319. Novobiocin Sodium		388. Prochlorperazine Mesylate
320. Novobiocin Tablets		389. Procyclidine Hydrochloride
321. Nux Vomica		390. Progesterone
322. Octyl Gallate		391. Proguanil Hydrochloride
323. Oestradiol Benzoate		392. Promazine Hydrochloride
324. Olive Oil		393. Promazine Injection
325. Opium		394. Promazine Tablets
326. Opium, Powdered		395. Promethazine Theoclate
327. Orange Peel, Dried Bitter		396. Propranolol Hydrochloride
328. Orphenadrine Hydrochloride		397. Propyl Gallate
329. Oxygen		398. Propyliodone
330. Oxyphenbutazone		399. Propyliodone Injection
331. Oxyphenbutazone Tablets		400. Propyliodone Oily Injection
332. Oxyphencyclimine Hydrochloride		401. Propylthiouracil
333. Oxytetracycline Tablets		402. Pyrazinamide
334. Oxytocin Tablets		403. Pyridostigmine Bromide
335. Paramethadione		404. Pyrimethamine
336. Paramomycin Capsules		405. Pyroxylin
337. Paramomycin Sulphate	406. Quillaia
338. Pempidine Tartrate	407. Quinidine Sulphate
339. Penicillamine	408. Quinine Dihydrochloride Injection
340. Penicillamine Hydrochloride	409. Rabies Antiserum
341. Pentamidine Isethionate	410. Rabies Vaccine
342. Pentamidine Injection	411. Sesame Oil
343. Pentolinium Tartrate Tablets	412. Soda Lime
344. Peppermint Oil	413. Sodium Acetate
345. Percutaneous Bacillus Calmette-Guérin Vaccine	414. Sodium Acetrizoate Injection
346. Perphenazine	415. Sodium Antimonylgluconate
347. Perphenazine Tablets	416. Sodium Antimonylgluconate Injection
348. Pethidine Tablets	417. Sodium Aurothiomalate
349. Phenacetin	418. Sodium Bicarbonate Compound Tablets
350. Phenazocine Hydrobromide	419. Sodium Bromide
351. Phenazocine Injection

First Schedule—continued

420. Sodium Calciumedetate	466. Tetanus Vaccine (Alum Precipitated)
421. Sodium Chromate (51 Cr) Solution	467. Tetanus Vaccine (Simple Solution)
422. Sodium Citrate Tablets	468. Tetrachloroethylene
423. Sodium Cyclamate	469. Tetrachloroethylene Capsules
424. Sodium Diatrizoate	470. Tetracycline Tablets
425. Sodium Diatrizoate Injection	471. Thiomersal
426. Sodium Fluoride	472. Thiopentone Sodium
427. Sodium Fusidate Capsules	473. Thiopentone Injection
428. Sodium Hydroxide	474. Thioridazine Hydrochloride
429. Sodium Iodide (131 I) Injection	475. Thyroid
430. Sodium Iodide (125 I) Solution	476. Thyroxine Sodium
431. Sodium Iodide (131 I) Solution	477. Tolnaftate
432. Sodium Iodohippurate (131 I) Injection	478. Tolazoline Hydrochloride
433. Sodium Iothalamate Injection	479. Tolazoline Tablets
434. Sodium Lauryl Sulphate	480. Tolbutamide
435. Sodium Phosphate (32 P) Injection	481. Tolu Balsam
436. Sodium Stibogluconate	482. Tranylcypromine Sulphate
437. Sodium Stibogluconate Injection	483. Tranylcypromine Tablets
438. Solapsone	484. Triamterene Capsules
439. Solapsone Tablets	485. Trichloroethylene
440. Spironolactone	486. Tricyclamol Chloride
441. Staphylococcus Antitoxin	487. Tricyclamol Tablets
442. Stibophen	488. Tryparsamide
443. Stibophen Injection	489. Tryparsamide Injection
444. Stramonium	490. Tuberculin, Old
445. Sulphadiazine Sodium	491. Tuberculin Purified Protein Derivative
446. Sulphadimethoxine	492. Tubocurarine Chloride
447. Sulphadimidine Injection	493. Tubocurarine Injection
448. Sulphadimidine Sodium	494. Turpentine Oil
449. Sulphamethizole	495. Typhoid-Paratyphoid A and B
450. Sulphamethoxydiazine	496. Typhoid-Paratyphoid A and B and
451. Sulphamethoxypridazine	Cholera Vaccine
452. Sulphapyridine	497. Typhoid-Paratyphoid A and B and
453. Sulphinpyrazone	Tetanus Vaccine
454. Sulphobromophthalein Sodium	498. Typhoid-Paratyphoid A, B and
455. Sulphomyxin Injection	C Vaccine
456. Sulphomyxin Sodium	499. Undecenoic Acid
457. Sulthiame	500. Urea
458. Suramin	501. Urea Injection
459. Suramin Injection	502. Vancomycin Hydrochloride
460. Suxamethonium Chloride	503. Vancomycin Injection
461. Suxamethonium Bromide	504. Vinyl Ether
462. Suxamethonium Chloride Injection	505. Vitamin A Ester Concentrate
463. Testosterone	506. Yellow Fever Vaccine
464. Testosterone Phenylpropionate Injection	507. Zinc Undecenoate
465. Tetanus and Pertussis Vaccine	508. Zinc Undecenoate Ointment

____________

SECOND SCHEDULE  Regulation 10 (3.).

Allowable Compounds (if any) of Certain Drugs or Medicinal Preparations

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Allowable Compounds (if any)
1	Acepifylline...............................................................	—
2	Acetylsulphafurazole..............................................	—
3	Acetylcysteine..........................................................	—
4	Acrylic Resin............................................................	—
5	Adrenaline Hydrochloride.....................................	—
6	Albumaid XP............................................................	—
7	Aluminium Sodium Silicate...................................	—
8	Amino Acids.............................................................	Amino Acids with Sorbitol
Amino Acids with Sorbitol and Alcohol
9	Amphotericin B.......................................................	Tetracycline, B.P.C. with buffering agent and Amphotericin B

Second Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Allowable Compounds (if any)
10	Ampicillin......................................................................	—
11	Ampicillin Trihydrate.................................................	—
12	Antazoline Sulphate....................................................	Naphazoline Nitrate with Antazoline Sulphate
13	Ascorbic Acid...............................................................	Vitamin A with Thiamine Hydrochloride, Riboflavine, Nicotinamide, Vitamin D and Ascorbic Acid
Ferrous Sulphate mixture and Ferrous Sulphate mixture C.F. of the Australian Pharmaceutical Formulary
Ferrous Sulphate mixture Prescribers List
Ferrous Sulphate mixture Prescribers List Children’s Section
14	Attapulgite....................................................................	Dihydrostreptomycin Sulphate with Pectin, Dried Aluminium Hydroxide Gel and Attapulgite
15	Bacitracin......................................................................	Neomycin Sulphate with Polymyxin B Sulphate and Bacitracin
16	Bacitracin Zinc.............................................................	Neomycin Undecenoate with Bacitracin Zinc
Polymyxin B Sulphate with Neomycin Sulphate and Bacitracin Zinc
17	Belladonna Herb, Prepared........................................	Phenobarbitone with Belladonna Herb, Prepared
18	Belladonna, Dry Extract............................................	Phenolphthalein with Aloin, Strychnine, B.P.C. 1959, Ipecacuanha and Dry Extract of Belladonna
19	Betamethasone ...........................................................	Betamethasone Acetate with Betamethasone
20	Betamethasone Acetate.............................................	Betamethasone with Betamethasone Acetate
21	Betamethasone Sodium Phosphate	—
22	Betamethasone Phosphate.........................................	—
23	Betamethasone Valerate............................................	Clioquinol with Betamethasone Valerate
24	Brompheniramine Maleate........................................	—
25	Calciferol.......................................................................	—
26	Calcium Di-Oxytetracycline......................................	—
27	Capsicum Oleoresin.....................................................	Cascara Dry Extract with Phenolphthalein, Sodium Tauroglycocholate, B.P.C. 1954 and Capsicum Oleoresin
28	Carbachol.....................................................................	Hypromellose 4500 with Carbachol
29	Carbinoxamine Maleate............................................	—
30	Cascara Dry Extract....................................................	Phenolphthalein with Capsicum Oleoresin, Sodium Tauroglycocholate, B.P.C. 1954 and Cascara Dry Extract
31	Ceratonia B.P.C. 1949................................................	—
32	Chloramine, B.P.C.......................................................	—
33	Chloramphenicol.........................................................	Polymyxin B Sulphate with Chloramphenicol
Hydrocortisone Acetate with Chloramphenicol
34	Chloramphenicol Palmitate, B.P.C.	—
35	Chloramphenicol Stearate.........................................	—
36	Chlorhexidine Gluconate...........................................	—
37	Chlorpheniramine Maleate........................................	—
38	Chlorpromazine Hydrochloride	—
39	Choline Theophyllinate..............................................	Guaiphenesin with Choline Theophyllinate
40	Clemizole Tannate......................................................	—
41	Clioquinol......................................................................	Betamethasone Valerate with Clioquinol
Flumethasone Pivalate with Clioquinol
42	Colistin Sulphate.........................................................	Neomycin Sulphate with Colistin Sulphate
43	Cortisone Acetate........................................................	—
44	Cyclizine Hydrochloride ...........................................	Ergotamine Tartrate with Caffeine and Cyclizine Hydrochloride

45	Cymogran.....................................................................	—
46	Cyproheptadine Hydrochloride	—
47	Danthron.......................................................................	Dioctyl Sodium Sulphosuccinate, B.P.C. with Danthron
48	Demecarium Bromide.................................................	—
49	Demethylchlortetracycline Hydrochloride	Nystatin with Demethylchlortetracycline Hydrochloride.
50	Dexamethasone ..........................................................	Pramycetin Sulphate with Gramicidin and Dexamethasone

Second Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Allowable Compounds (if any)
51	Dexamethasone Metasulphobenzoate	Framycetin Sulphate with Gramicidin and Dexamethasone Metasulphobenzoate
52	Dexchlorpheniramine Maleate	—
53	Dextrans.........................................................................	Dextrose with Dextrans
Sodium Chloride with Dextrans
54	Diazepam......................................................................	—
55	Dichloralphenazone.....................................................	—
56	Dicyclomine Hydrochloride.......................................	Doxylamine Succinate with Pyridoxine Hydrochloride and Dicyclomine Hydrochloride
57	Dienoestrol.....................................................................	—
58	Diethanolamine Fusidate............................................	—
59	Digoxin...........................................................................	—
60	Dihydrocodeine Tartrate.............................................	—
61	Dihydrostreptomycin Sulphate, B.P. 1958	Attapulgite with Pectin, Dried Aluminium Hydroxide Gel and Dihydrostreptomycin Sulphate, B.P. 1958
Kaolin with Pectin, Aluminium Hydroxide Gel and Dihydrostreptomycin Sulphate, B.P. 1958
62	Dihydrotachysterol ......................................................	—
63	Dimethicone, B.P.C.....................................................	—
64	Dioctyl Sodium Sulphosuccinate, B.P.C.	Danthron with Dioctyl Sodium Sulphosuccinate, B.P.C.
Oxyphenisatin Acetate with Dioctyl Sodium Sulphosuccinate B.P.C.
65	Diphenhydramine Hydrochloride	Ergotamine Tartrate with Caffeine Citrate and Diphenhydramine Hydrochloride
66	Diphenylpyraline Hydrochloride	—
67	Diphtheria Vaccine......................................................	Diphthoria and Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed)
Diphtheria, Tetanus (Purified Toxoid Aluminium Phosphate Adsorbed) and Pertussis Vaccine
68	Doxycycline Hyclate...................................................	—
69	Doxylamine Succinate................................................	Dicyclomine Hydrochloride with Pyridoxine Hydrochloride and Doxylamine Succinate
70	Ecothiopate Iodide.......................................................	—
71	Ergometrine Maleate...................................................	Oxytocin with Ergometrine Maleate
72	Ergotamine Tartrate....................................................	Caffeine with Ergotamine Tartrate
Caffeine with Cyclizine Hydrochloride and Ergotamine Tartrate
Caffeine Citrate with Diphenhydramine Hydrochloride and Ergotamine Tartrate
Caffeine with Meclozine Hydrochloride and Ergotamine Tartrate
73	Erythromycin Estolate................................................	—
74	Erythromycin Stearate................................................	—
75	Ethosuximide................................................................	—
76	Ferric Hydroxide..........................................................	—
77	Ferrous Aminoacetosulphate.....................................	—
78	Ferrous Succinate.........................................................	—
79	Flumethasone Pivalate................................................	Clioquinol with Flumethasone Pivalate
80	Fluphenazine Hydrochloride......................................	—
81	Framycetin Sulphate ...................................................	Light Kaolin with Framycetin Sulphate
Doxamethasone with Framycetin Sulphate and Gramicidin
Gramicidin and Dexamethasone Metasulphobenzoate with Framycetin Sulphate
82	Galactomin, Formula No. 17	—
83	Galactomin, Formula No. 19	—
84	Glucose Indicator, Blood............................................	—
85	Glucose Indicator, Urine.............................................	—
86	Goat’s Milk, Dehydrated............................................	—
87	Goat’s Milk....................................................................	—
88	Gramicidin.....................................................................	Polymyxin B Sulphate with Neomycin Sulphate and Gramicidin

Second Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Allowable Compounds (if any)
88—cont.	Neomycin Sulphate with Thonzonium Bromide, Thonzylamine Hydrochloride, Hydrocortisone Acetate and Gramicidin
Framycetin Sulphate with Dexamethasone and Gramicidin
Framycetin Sulphate with Dexamethasone Metasulphobenzoate and Gramicidin
Neomycin Sulphate with Nystatin, Triamcinolone Acetonide and Gramicidin
89	Guaiphenesin, B.P.C...................................................	Theophylline with Guaiphenesin, B.P.C.
90	Hydrocortisone............................................................	Polymyxin B Sulphate with Neomycin Sulphate and Hydrocortisone
Neomycin Sulphate with Hydrocortisone
Natamycin with Neomycin Sulphate and Hydrocortisone
91	Hydrocortisone Acetate..............................................	Neomycin Sulphate with Hydrocortisone Acetate
Neomycin Sulphate with Gramicidin, Thonzonium Bromide, Thonzylamine Hydrochloride and Hydrocortisone Acetate
Oxytetracycline Hydrochloride with Hydrocortisone Acetate
Chloramphenicol with Hydrocortisone Acetate
92	Hyoscine Hydrobromide............................................	Hypromellose 4500 with Hyoscine Hydrobromide
Papaveretum with Hyoscine Hydrobromide
Pethidine Hydrochloride with Hyoscine Hydrobromide
Morphine Sulphate with Hyoscine Hydrobromide
93	Idoxuridine...................................................................	—
94	Ipecacuanha ................................................................	Phenolphthalein with Aloin, Dry Extract of Belladonna, Strychnine, B.P.C. 1959 and Ipecacuanha
95	Isoniazid........................................................................	Sodium Aminosalicylate with Isoniazid
96	Isoprenaline Hydrochloride.......................................	—
97	Kanamycin Sulphate, B.P.C......................................	—
98	Lauryl Dimethylbenzyl Ammonium Chloride	‘TERIC’ N8 with Lauryl Dimethylbenzyl Ammonium Chloride
99	Levallorphan Tartrate ................................................	Pethidine Hydrochloride with Levallorphan Tartrate
100	Lignocaine Hydrochloride ........................................	Polymyxin B Sulphate with Propylene Glycol and Lignocaine Hydrochloride
101	Lincomycin Hydrochloride .......................................	—
102	Lofenalac......................................................................	—
103	Lypressin.......................................................................	—
104	Magnesium Aluminium Hydroxide	—
105	Magnesium Chloride...................................................	Sodium Chloride with Ammonium Chloride, Potassium Chloride and Magnesium Chloride
Sodium Chloride with Potassium Chloride, Sodium Lactate and Magnesium Chloride
106	Magnesium Hydroxide, B.P.C.	Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C.
Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C. and Oxethazaine
Aluminium Hydroxide Gel Dried with Magnesium Hydroxide, B.P.C.
Aluminium Hydroxide Gel Dried with Magnesium Trisilicate and Magnesium Hydroxide, B.P.C.
107	Mebhydrolin Napadisylate, B.P.C.	—
108	Meclastine Hydrogen Fumarate	—
109	Meclozine Hydrochloride..........................................	Ergotamine Tartrate with Caffeine and Meclizine Hydrochloride
110	Meglumine....................................................................	Theophylline with Meglumine
111	Methacycline................................................................	—
112	Methdilazine Hydrochloride .....................................	—
113	Methenamine Mandelate ..........................................	—
114	Minafen.........................................................................	—

Second Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Allowable Compounds (if any)
115	Morphine Tartrate.......................................................	Morphine Tartrate with Tacrine
116	Nalidixic Acid, B.P.C.................................................	—
117	Naphazoline Nitrate....................................................	Naphazoline Nitrate with Antazoline Sulphate
118	Natamycin....................................................................	Neomycin Sulphate with Hydrocortisone and Natamycin
119	Neomycin Sulphate ....................................................	Hydrocortisone Acetate with Neomycin Sulphate
Hydrocortisone with Neomycin Sulphate
Colistin Sulphate with Neomycin Sulphate
Polymyxin B Sulphate with Bacitracin Zinc and Neomycin Sulphate
Kaolin with Neomycin Sulphate
Polymyxin 13 Sulphate with Gramicidin and Neomycin-Sulphate
Polymyxin B Sulphate with Hydrocortisone and Neomycin Sulphate
Prednisolone Sodium Phosphate with Neomycin Sulphate
Bacitracin with Polymyxin B Sulphate and Neomycin Sulphate
Thonzonium Bromide with Thonzylamine Hydrochloride, Hydrocortisone Acetate, Gramicidin and Neomycin Sulphate
Gramicidin with Nystatin, Triamcinolone Acetonide and Neomycin Sulphate
Natamycin with Hydrocortisone and Neomycin Sulphate
120	Neomycin Undecenoate.............................................	Bacitracin Zinc with Neomycin Undecenoate
121	Neostigmine Methylsulphate....................................	—
122	Nicotinamide................................................................	Vitamin A with Thiamine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D
123	Nitrofurantoin .............................................................	—
124	Noradrenaline Acid Tartrate .....................................	—
125	Nortriptyline Hydrochloride......................................	—
126	Nystatin.........................................................................	Tetracycline, B.P.C. with a buffering agent and Nystatin
Demethylchlortetracycline with Nystatin
Tetracycline Hydrochloride with Nystatin
Gramicidin with Neomycin Sulphate
Triamcinolone Acetonide and Nystatin
Oxytetracycline Dihydrate with Nystatin
127	Nutramigen...................................................................	—
128	Octatropine Methylbromide......................................	—
129	Orciprenaline Sulphate ..............................................	—
130	Oxytetracycline Dihydrate.........................................	Nystatin with Oxytetracycline Dihydrate
131	Oxytetracycline Hydrochloride	Polymyxin B Sulphate with Oxytetracycline Hydrochloride
Hydrocortisone Acetate with Oxytetracycline Hydrochloride
132	Oxyphenisatin Acetate...............................................	Dioctyl Sodium Sulphosuccinate, B.P.C. with Oxyphenisatin Acetate
133	Oxethazaine.................................................................	Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C. and Oxethazaine
134	Oxytocin........................................................................	Ergometrine Maleate with Oxytocin
135	Pancreatin.....................................................................	—
136	Pancreatin Enzyme, 4 times U.S.N.F. XII strength	—
137	Papaveretum, B.P.C....................................................	Hyoscine Hydrobromide with Papaveretum, B.P.C.
138	Penicillin, Benethamine, B.P.C.................................	Procaine Penicillin with Benethamine Penicillin, B.P.C, and Sodium Penicillin
139	Penicillin, Benzathine................................................	Procaine Penicillin with Potassium Penicillin and Benzathine Penicillin
140	Penicillin, Benzyl........................................................	Procaine Penicillin with Benzyl Penicillin
141	Penicillin, Phenoxymethyl (Benzathine, Hydrabamine, or Calcium Salt)	—

Second Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Allowable Compounds (if any)
142	Penicillin, Potassium....................................................	Benzathine Penicillin with Procaine Penicillin and Potassium Penicillin
143	Penicillin, Procaine.......................................................	Benethamine Penicillin, B.P.C. with Sodium Penicillin and Procaine Penicillin
Benzathine Penicillin with Potassium Penicillin and Procaine Penicillin
Benzyl Penicillin with Procaine Penicillin
144	Penicillin, Sodium.........................................................	Procaine Penicillin with Benethamine Penicillin, B.P.C. and Sodium Penicillin
145	Pentobarbitone...............................................................	Barbitone Sodium with Phenobarbitone Sodium and Pentobarbitone
146	Pericyazine......................................................................	—
147	Pertussis Vaccine...........................................................	Diphtheria, Tetanus (Purified Toxoid Aluminium Phosphate Adsorbed) and Pertussis Vaccine
148	Pethidine Hydrochloride..............................................	Levallorphan Tartrate with Pethidine Hydrochloride Hyoscine Hydrobromide with Pethidine Hydrochloride
149	Phenethicillin Potassium..............................................	—
150	Pheniramine Maleate....................................................	—
151	Phenytoin, B.P.C............................................................	—
152	Pholcodine......................................................................	—
153	Pipenzolate Methobromide.........................................	—
154	Pituitary (Posterior Lobe), Powdered, B.P.C.	—
155	Plasma Substitute (Polypeptide)	—
156	Polyisobutylene..............................................................	—
157	Polymyxin B Sulphate..................................................	Chloramphenicol with Polymyxin B Sulphate
Oxytetracycline Hydrochloride with Polymyxin B Sulphate
Polymyxin B Sulphate with Bacitracin Zinc and Neomycin Sulphate
Polymyxin B Sulphate with Neomycin Sulphate and Gramicidin
Propylene Glycol with Acetic Acid and Polymyxin B Sulphate
Neomycin Sulphate with Hydrocortisone and Polymyxin B Sulphate
Bacitracin with Neomycin Sulphate and Polymyxin B Sulphate
Lignocaine Hydrochloride with Propylene Glycol and Polymyxin B Sulphate
158	Polyvinyl Alcohol..........................................................	Pilocarpine Nitrate and Polyvinyl Alcohol
159	Prednisolone...................................................................	—
160	Prednisolone Acetate....................................................	—
161	Methylprednisolone......................................................	—
162	Prednisolone Sodium Hemisulphate	Sulphaethidole with Prednisolone Sodium Hemisulphate
163	Prednisolone Sodium Phosphate	Neomycin Sulphate with Prednisolone Sodium Phosphate
164	Prednisolone Pivalate...................................................	—
165	Primidone........................................................................	—
166	Promethazine Hydrochloride.......................................	—
167	Pseudoephedrine Hydrochloride	—
168	Pyrantel Embonate.......................................................	—
169	Pyridoxine Hydrochloride............................................	Dicyclomine Hydrochloride with Doxylamine Succinate and Pyridoxine Hydrochloride
170	Prosobee..........................................................................	—
171	Riboflavine.....................................................................	Vitamin A with Thiamine Hydrochloride, Nicotinamide, Ascorbic Acid, Vitamin D and Riboflavine
173	Salbutamol.....................................................................	—
173	Senna Fruit......................................................................	—
174	Silver Nitrate, Toughened............................................	—
175	Similac Isomil................................................................	—
176	Sobee...............................................................................	—

Second Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Allowable Compounds (if any)
177	Sodium Acid Citrate.....................................................	—
178	Sodium Lactate.............................................................	Potassium Chloride with Sodium Chloride and Sodium Lactate
Potassium Chloride with Magnesium Chloride, Sodium Chloride and Sodium Lactate
Potassium Chloride with Dextrose and Sodium Lactate Sodium Chloride with Dextrose and Sodium Lactate
Sodium Chloride with Sodium Lactate
179	Sodium Potassium Tartrate, B.P.C.	Compound Effervescent Powder, B.P.C.
180	Sodium Tauroglycocholate, B.P.C. 1954	Cascara Dry Extract with Phenolphthalein, Capsicum Oleoresin and Sodium Tauroglycocholate, B.P.C. 1954
181	Sorbitol............................................................................	Amino Acids with Sorbitol
Amino Acids with Sorbitol and Alcohol
182	Soyalac	—
183	Strychnine, B.P.C. 1959..............................................	Phenolphthalein with Aloin, Dry Extract of Belladonna, Ipecacuanha and Strychnine, B.P.C. 1959
184	Sulphacetamide, B.P.C................................................	Sulphadiazine with Sulphamerazine, B.P. 1958 and Sulphacetamide, B.P.C.
185	Sulphaethidole...............................................................	Prednisolone Sodium Hemisulphate with Sulphaethidole
186	Sulphafurazole..............................................................	—
187	Sulphamethizole...........................................................	—
188	Sulphamethoxazole......................................................	Trimethoprim with Sulphamethoxazole
189	Sulphamerazine, B.P. 1958.........................................	Sulphadiazine with Sulphathiazole, B.P.C. and Sulphamerazine, B.P. 1958
Sulphadiazine with Sulphacetamide, B.P.C. and Sulphamerazine, B.P. 1958
Sulphadiazine with Sulphadimidine and Sulphamerazine B.P. 1958
190	Sulphaphenazole, B.P.C..............................................	—
191	Sulphathiazole, B.P.C...................................................	Sulphadiazine with Sulphamerazine, B.P. 1958 and Sulphathiazole, B.P.C.
192	Surgical Cement...........................................................	—
193	Surgical Cement Solvent.............................................	—
194	Tacrine............................................................................	Morphine Sulphate with Tacrine
Morphine Tartrate with Tacrine
195	‘TERIC’ N8...................................................................	Lauryl Dimethylbenzyl Ammonium Chloride with ‘TERIC’ N8
196	Testosterone Decanoate..............................................	Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate
197	Testosterone Isocaproate............................................	Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate
Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate

198	Testosterone Phenylpropionate	Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone. Isocaproate
Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate
199	Testosterone Propionate..............................................	Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate
Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate
200	Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed)	Diphtheria and Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed)
Diphtheria, Pertussis and Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed)
201	Tetracycline, B.P.C.......................................................	Tetracycline, B.P.C. with a buffering agent
Tetracycline, B.P.C. with a buffering agent and Amphotericin B
Tetracycline, B.P.C. with a buffering agent and Nystatin

Second Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Allowable Compounds (if any)
202	Tetracycline Hydrochloride.......................................	Tetracycline Hydrochloride with Nystatin Procaine Hydrochloride with Tetracycline Hydrochloride
203	Thiamine Hydrochloride............................................	Riboflavine with Nicotinamide, Ascorbic Acid, Vitamin A, Vitamin D and Thiamine Hydrochloride
204	Thioridazine.................................................................	—
205	Thiotepa........................................................................	—
206	Thonzonium Bromide................................................	Neomycin Sulphate with Gramicidin, Thonzylamine Hydrochloride, Hydrocortisone Acetate and Thonzonium Bromide
207	Thonzylamine Hydrochloride	Neomycin Sulphate with Gramicidin, Hydrocortisone Acetate, Thonzonium Bromide and Thonzylamine Hydrochloride
208	Tiemonium Iodide......................................................	—
209	Tragacanth, Indian (Gum Karaya)	—
210	Triamcinolone Acetonide..........................................	Gramicidin with Neomycin Sulphate, Nystatin and Triamcinolone Acetonide
211	Triclofos Sodium.........................................................	—
212	Trifluoperazine Hydrochloride	—
213	Triglyde.........................................................................	—
214	Trimeprazine Tartrate, B.P.C.	—
215	Trimethoprim...............................................................	Trimethoprim with Sulphamethoxazole
216	Triprolidine Hydrochloride ......................................	—
217	Vinyl Acetate...............................................................	Vinyl Pyrrolidone and Vinyl Acetate with Benzocaine
218	Vinyl Pyrrolidone........................................................	Vinyl Acetate and Vinyl Pyrrolidone with Benzocaine
219	Viprynium Embonate................................................	—
220	Vitamin A.....................................................................	Thiamine Hydrochloride with Riboflavine, Nicotinamide, Ascorbic Acid, Vitamin D and Vitamin A
221	Vitamin D.....................................................................	Thiamine Hydrochloride with Riboflavine, Nicotinamide, Ascorbic Acid, Vitamin A and Vitamin D

___________

 

THIRD SCHEDULE Regulation 11.

Drugs and Medicinal Preparations Additional to the Drugs and Medicinal Preparations in the British Pharmacopoeia

1. Acepifylline	20. Aluminium Sodium Polyhydroxy Monocarbonate Hexitol Complex
2. Acetazolamide Sodium	21. Aluminium Sodium Silicate
3. Acetohexamide	22. Amantadine Hydrochloride
4. Acetylcholine Chloride	23. Amaranth Solution, A.P.F.
5. Acetylcysteine	24. Amaranth Solution, Compound,
6. Acetyl Sulphafurazole	A.P.F.
7. Acidified Golden Syrup, A.P.F. 1955	25. Amaranth Solution, B.P.C.
8. Acriflavine, B.P.C. 1963	26. Ambenonium Chloride
9. Acrylic Resin	27. Amino Acids
10. Adrenaline Hydrochloride	28. Aminocaproic Acid
11. Adrenaline Mucate	29. Aminosalicylic Acid
12. Albumaid XP	30. Amitriptyline Embonate
13. Aldosterone	31. Ammonia Aromatic Spirit, B.P.C.
14. Aloin, B.P.C.	32. Ammonia Solution, strong, B.P.C.
15. Almond Oil Volatile Bitter, B.P.C. 1959	33. Ammonium Acetate Solution, strong,
16. Aloxiprin	B.P.C.
17. Alprenolol Hydrochloride	34. Ammonium Bicarbonate, B.P.C.
18. Aluminium Acetate Solution, B.P.C.	35. Amphotericin B
19. Aluminium Hydroxide Mixture, A.P.F.	36. Angiotensin Amide

Third Schedule—continued

37. Antazoline Mesylate, B.P.C.	101. Dexamethasone Metasulphobenzoate
38. Antazoline Sulphate	102. Dexamethasone Sodium Phosphate
39. Anti-Haemophilic Factor of Animal Origin	103. Dexchlorpheniramine Maleate
40. Attapulgite	104. Dextrans
41. Bacitracin Zinc	105. Dextriferron
42. Belladonna Suppository, B.P. 1948	106. Dibenzepin Hydrochloride
43. Benzalkonium Chloride	107. Diethanolamine Fusidate, B.P.C.
44. Benzoin Compound Tincture, B.P.C.	108. Diethazine Hydrochloride, B.P. 1963
45. Bephenium Hydroxynaphthoate, B.P.C.	109. Dihydroergotamine Mesylate
46. Betahistine Hydrochloride	110. Dihydroergotoxine Mesylate
47. Betamethasone Acetate	111. Dihydrostreptomycin Sulphate, B.P. 1958
48. Betamethasone Phosphate	112. Dimethicone, B.P.C.
49. Black Snake Antivenene	113. Dimethindene Maleate
50. Biperiden Hydrochloride	114. Dioctyl Sodium Sulphosuccinate, B.P.C.
51. Bismuth Subgallate, B.P.C.	115. Diphenylpyraline Hydrochloride
52. Brompheniramine Maleate	116. Diphtheria Vaccine (Purified toxoid aluminium phosphate) diluted
53. Brown Snake Antivenene	117. Diphtheria and Tetanus Vaccine, Adult
54. Buchu Concentrated Infusion, B.P.C. 1954	118. Disodium Cromoglycate
55. Cade Oil, B.P.C.	119. Doxycycline Hyclate
56. Caffeine and Sodium Benzoate, B.P.C. 1954	120. Doxylamine Succinate
57. Caffeine Citrate, B.P.C. 1959	121. Droperidol
58. Calcium Di-Oxytetracycline	122. Ephedrine, B.P.C.
59. Calcium Gluconogalactogluconate	123. Erythrityl Tetranitrate
60. Capreomycin Sulphate	124. Erythromycin Ethyl Succinate
61. Capsicum Ointment, B.P.C.	125. Erythromycin Glucoheptonate
62. Capsicum Oleoresin	126. Erythromycin Lactobionate
63. Carbamazepine	127. Ethanolamine Oleate
64. Carbenoxolone Sodium	128. Ethoxzolamide
65. Carbinoxamine Maleate	129. Ethylidene Dicoumarin
66. Cardamom Aromatic Tincture, B.P.C.	130. Ethylnoradrenaline Hydrochloride
67. Catechu Tincture, B.P.C.	131. Ethyloestrenol
68. Cephalothin Sodium	132. Ferric Hydroxide
69. Ceratonia B.P.C. 1949	133. Ferrous Aminoacetosulphate
70. Cetomacrogol Emulsifying Wax, B.P.C.	134. Ferrous Phosphate Compound, Syrup B.P.C.
71. Charcoal	135. Flumethasone Pivalate
72. Chloramine, B.P.C.	136. Fluorouracil Sodium
73. Chloramphenicol Palmitate, B.P.C.	137. Fluphenazine Enanthate
74. Chloramphenicol Stearate	138. Flurandrenolone Acetonide
75. Chloramphenicol Succinate	139. Framycetin Sulphate
76. Chlorhexidine Acetate	140. Galactomin, Formula No. 17
77. Chlorhexidine Gluconate	141. Galactomin, Formula No. 19
78. Cholestyramine	142. Gall and Opium Ointment, B.P.C. 1963
79. Clemizole Hydrochloride	143. Gelsemium Tincture, B.P.C.
80. Clemizole Tannate	144. Gentamicin Sulphate
81. Clopamide	145. Ginger Syrup, B.P.C.
82. Clorexolone	146. Glibenclamide
83. Coal Tar, B.P.C.	147. Glucagon Hydrochloride
84. Coal Tar Solution Strong, B.P.C.	148. Glucose Indicator-Blood
85. Cochineal Tincture, B.P. 1948	149. Glucose Indicator-Urine
86. Coconut Oil, B.P.C. 1949	150. Glycerophosphate Compound Syrup, A.P.F.
87. Colophony Ointment, B.P.C. 1959	151. Glycopyrronium Bromide
88. Copper Sulphate, B.P.C.	152. Glymidine
89. Creosote, B.P.C. 1959	153. Goat’s Milk, Dehydrated
90. Cyclothiazide	154. Goat’s Milk, Whole (Sterilised)
91. Cycrimine Hydrochloride	155. Gramicidin
92. Cymogran	156. Guaiphenesin, B.P.C.
93. Cytosine Arabinoside Hydrochloride	157. Hamamelis Liquid Extract, B.P.C.
94. Danthron	158. Hexocyclium Methylsulphate
95. Death Adder Antivenene	159. Haemodialysis Fluid—Concentrate
96. Debrisoquine	160. Hydrargaphen
97. Demecarium Bromide	161. Hydromorphone Hydrochloride
98. Deoxycortone Pivalate, B.P. 1963	162. Hydroxyprogesterone
99. Desferrioxamine Mesylate
100. Deslanoside

Third Schedule—continued

163. Hyoscine Butylbromide	219. Methsuximide
164. Hyoscine Methobromide	220. Methyclothiazide
165. Hypophosphorous Acid, Dilute,	221. Methylphenobarbitone, B.P.C. 1963
B.P.C. 1963	222. Methylprednisolone Acetate
166. Hypromellose 4500	223. Methylprednisolone Sodium Succinate
167. Indomethacin	224. Methysergide Maleate
168. Influenza Vaccine—Sub Unit type	225. Metyrapone
(Desoxycholate Treated)	226. Minafen
169. Injection of Amino Acid with	227. Minocycline Hydrochloride
Sorbitol and Alcohol	228. Morphine Tartrate
170. Injection of Casein Hydrolysate with	229. Myrrh Tincture, B.P.C.
Laevulose and Alcohol	230. Nalidixic Acid, B.P.C.
171. Injection of Dextran with Dextrose	231. Nandrolone Hexoxyphenyl Propionate
172. Injection of Potassium Chloride with Sodium Lactate and Dextrose	232. Natamycin
173. Injection of Sodium Chloride with Potassium Chloride, Calcium Chloride and Dextrose	233. Neomycin Undecenoate
174. Injection of Sodium Chloride with Sodium Lactate and Dextrose	234. Nitrazepam
175. Insect Allergen Extract—Honey Bee	235. Nitromin
176. Insect Allergen Extract—Jumper Ant	236. Nutramigen
177. Insect Allergen Extract—Paper Wasp	237. Octatropine Methylbromide
178. Insulin Injection, specially purified	238. Oestradiol Dipropionate, B.P.C. 1954
179. Insulin Isophane Injection, specially purified	239. Oestrone, B.P.C. 1954
180. Insulin Injection, Special P (Pig)	240. Oily Opthalmic Vehicle, A.P.F. 1955
181. Invert Sugar	241. Orange Syrup, B.P.C.
182. Iron Polymaltose Complex	242. Orange Tincture, B.P.C.
183. Isoprenaline Hydrochloride	243. Oxethazaine
184. Isopropamide Iodide	244. Oxprenolol Hydrochloride
185. Kanamycin Sulphate, B.P.C.	245. Oxycodone Pectinate
186. Lanatoside-C	246. Oxymel, B.P.C.
187. Lauryl Dimethyl Benzyl Ammonium Chloride	247. Oxymel of Squill, B.P.C.
188. Lavender Spike Oil, B.P.C.	248. Oxymetholone
189. Lead Subacetate Dilute Solution	249. Oxyphenisatin Acetate
190. Lead Subacetate Strong Solution B.P.C.	250. Oxyphenonium Bromide
191. Levodopa	251. Oxytetracycline
192. Lemon Oil Terpeneless, B.P.C.	252. Oxytocin
193. Lemon Tincture, B.P. 1958	253. Pancreatin Enzyme, U.S.N.F. XII
194. Leucovorin	254. Papaveretum, B.P.C.
195. Lincomycin Hydrochloride	255. Paraben Ophthalmic Phosphate Buffer, A.P.F. 1955
196. Lipopancreatin	256. Paraben Ophthalmic Vehicle, A.P.F. 1955
197. Lobelia Ethereal Tincture, B.P.C.	257. Paraffin Liquid Light, B.P.C. 1963
198. Lofenalac	258. Paramethasone Acetate
199. Lypressin	259. Pectin
200. Magenta, B.P.C.	260. Penicillinase
201. Magnesium-Aluminium Hydroxide	261. Penicillin Benethamine, B.P.C.
202. Magnesium Hydroxide, B.P.C.	262. Pentaerythritol Tetranitrate, diluted, B.P.C.
203. Maphenide Acetate	263. Pentazocine Lactate
204. Mebeverine Hydrochloride	264. Penthienate Methobromide
205. Mebhydrolin Napadisylate, B.P.C.	265. Pentobarbitone
206. Meclastine Hydrogen Fumarate	266. Pericyazine
207. Medroxyprogesterone Acetate	267. Pericyazine Mesylate
208. Melphalan	268. Peritoneal Dialysis Solution with Dextrose
209. Mepenzolate Bromide	269. Phenformin Hydrochloride
210. Mercaptomerin Sodium	270. Pheniramine Maleate
211. Mercuric Chloride, B.P.C.	271. Pheniramine Para-Aminosalicylate
212. Metaraminol Bitartrate	272. Phenol Ointment, B.P. 1948
213. Methacycline	273. Phenoxymethylpenicillin, Benzathine
214. Methaqualone Hydrochloride	274. Phenoxymethylpenicillin, Hydrabamine
215. Methdilazine Hydrochloride	275. Phensuximide, B.P.C.
216. Methenamine Mandelate	276. Phenthimentonium
217. Methenolone Acetate	277. Phenytoin, B.P.C.
218. Methoxamine Hydrochloride, B.P.C.	278. Phthalylsulphacetamide
279. Physostigmine, B.P.C.
280. Pilocarpine Hydrochloride
281. Pipenzolate Methobromide

Third Schedule—continued

282. Pituitary Hormone, Follicle-stimulating, Human	338. Stearic Acid, B.P.C.
283. Pituitary Hormone, Growth, Human	339. Stilboestrol Diphosphate
284. Pituitary (Posterior Lobe) Powdered, B.P.C.	340. Stone Fish Antivenene
285. Plasma Substitute (Polypeptide)	341. Streptokinase
286. Polyisobutylene	342. Strychnine, B.P.C. 1959
287. Polyoestradiol Phosphate	343. Sulphacetamide, B.P.C.
288. Polyvinyl Alcohol	344. Sulphaethidole
289. Potassium Chlorate, B.P.C.	345. Sulphamerazine B.P. 1958
290. Potassium Effervescent Tablets	346. Sulfamethoxazole
291. Potassium Perchlorate	347. Sulphaphenazole, B.P.C.
292. Practolol	348. Sulphasalazine
293. Prednisolone Acetate	349. Sulphasymazine
294. Prednisolone Sodium Succinate	350. Sulphathiazole, B.P.C.
295. Prednisolone Sodium Hemisulphate	351. Sulphurated Potash, B.P.C.
296. Prednisolone Tertiary Butyl Acetate	352. Sulphur Sublimed, B.P.C.
297. Procarbazine Hydrochloride	353. Surgical Cement
298. Prochlorperazine	354. Surgical Cement Solvent
299. Proscillaridin	355. Tacrine
300. Prosobee	336. Taipan Antivenene
301. Protriptyline Hydrochloride	357; Tartrazine, B.P.C. 1954
302. Pseudoephedrine Hydrochloride	358. ‘TERIC’ N8
303. Pumilio Pine Oil, B.P.C.	359. Testosterone Decanoate
304. Pyrantel Embonate	360. Testosterone Enanthate
305. Pyridine Aldoxime Methiodide	361. Testosterone Isocaproate
306. Quillaia Tineture, B.P.C.	362. Tetracosactrin
307. Quinethazone	363. Tetracycline, B.P.C.
308. Quinidine Bisulphate	364. Thiabendazole
309. Raspberry Syrup, B.P.C.	365. Thiethylperazine Malate
310. Rauwolfia Alkaloids	366. Thiethylperazine Maleate
311. Rauwolfia Serpentina, B.P.C.	367. Thioridazine
312. Red Back Spider Antivenene	368. Thonzonium Bromide
313. Rolitetracycline	369. Thonzylamine Hydrochloride
314. Rosemary Oil, B.P.C.	370. Thyrotrophin
315. Salbutamol	371. Tiemonium Iodide
316. Salicylamide	372. Tiger Snake Antivenene
317. Secbutobarbitone Sodium	373. Titanium Dioxide, B.P.C.
318. Senega, Concentrated Infusion, B.P.C. 1968	374. Tolazamide
319. Senna Fruit Extract (Standardised)	375. Tragacanth, Indian (Gum Karaya)
320. Siberian Fir Oil, B.P.C. 1949	376. Tragacanth Mucilage
321. Silver Protein, B.P.C.	377. Tretamine
322. Silver Protein Mild, B.P.C.	378. Tridihexethyl Chloride.
323. Similac Isomil	379. Triethanolamine, B.P.C.
324. Snake Bite Antivenene—Polyvalent	380. Triglyde
325. Sobee	381. Trimeprazine Tartrate, B.P.C.
326. Sodium Folate	382. Trimethoprim
327. Sodium Lactate	383. Trimipramine Maleate
328. Sodium Lactate Compound Injection, B.P. with Dextrose	384. Trimipramine Mesylate
329. Sodium Nitroprusside	385. Trolnitrate Phosphate
330. Sodium Potassium Tartrate, B.P.C.	386. Typhoid Vaccine
331. Sodium Tauroglycocholate, B.P.C. 1954	387. Typhoid and Cholera El Tor Combined Vaccine
332. Sorbide Nitrate	388. Vanillin
333. Sorbitol	389. Vasopressin Tannate
334. Soyalac	390. Vinblastine Sulphate
335. Squill Tincture, B.P.C.	391. Vincristine Sulphate
336. Stanolone	392. Vinyl Acetate
337. Stanozolol	393. Vinyl Pyrrolidone
394. Vitamin A
395. Vitamin D
396. Zinc Gelatin, B.P.C.

FOURTH SCHEDULE Regulation 12.

Additives

1. Acetone B.P.C.	15. Ether Anaesthetic B.P.
2. Alcohol (95%) B.P.	16. Eucalyptol B.P.C.
3. Arachis Oil B.P.	17. Eucalyptus Oil B.P.
4. Amethocaine Hydrochloride B.P.	18. Honey—Purified B.P.C.
5. Camphor B.P.	19. Maize Oil B.P.
6. Carmine Solution A.P.F.	20. Olive Oil B.P.
7. Citronella Oil B.P.C.	21. Peppermint Oil B.P.
8. Chlorhexidine Gluconate Solution B.P.	22. Sodium Thiosulphate B.P.C.
9. Chloroform B.P.	23. Solution of Burnt Sugar B.P.C. 1959
10. Concentrated Anise Water B.P.C.	24. Spirit Methylated Industrial B.P.
11. Concentrated Cinnamon Water B.P.C.	25. Syrup of Pholcodine Citrate B.P.C. 1959
12. Concentrated Peppermint Water B.P.	26. Turpentine Oil B.P.
13. Dextrose Monohydrate B.P.	27. Xylene B.P.C. 1949
14. Dilute Alcohols B.P.

__________

 

FIFTH SCHEDULE Regulation 14.

Pharmaceutical Benefits the Prescribing of Which is Subject to Conditions and Restrictions

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
1	Acetylcysteine.....................................................................	Cystic Fibrosis (mucoviscidosis)
2	(1) Aspirin with Paracetamol and Caffeine Tablets	Any disease or condition in a pensioner
(2) Aspirin with Codeine Phosphate and Pentobarbitone Sodium Tablets
3	Acrylic Resin......................................................................	Ileostomy or colostomy conditions
4	Albumaid XP......................................................................	With the written authority of the Director-General, Phenylketonuria
5	Aldosterone......................................................................... .	With the written authority of the Director-General, treatment of an acute crisis in adrenal cortical hypofunction (including Addison’s disease and salt-losing congenital adrenal hypoplasia)
6	Alprenolol Hydrochloride Injection	Idiopathic hypertrophic subaortic stenosis Right ventricular outflow tract obstruction Dissecting aneurysm, aortic
The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents
Serious arrhythmias
Thyrotoxicosis
7	Alprenolol Hydrochloride Tablets	With the written authority of the Director-General—
Idiopathic hypertrophic subaortic stenosis Right ventricular outflow tract obstruction Dissecting aneurysm, aortic
The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents
Serious arrhythmias
Thyrotoxicosis

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
8	Amantadine Hydrochloride..........................................	With the written authority of the Director-General, treatment of Parkinson’s disease in conjunction with Levodopa
9	Ambenonium Chloride..................................................	Myasthenia gravis
10	Aminocaproic Acid........................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
11	Aminosalicylic Acid......................................................	Tuberculosis
12	Amphotericin B Injection.............................................	Systemic mycoses
13	(1) Ampicillin Capsules, B.P........................................	Infections by susceptible organisms when these cannot be safely and effectively treated with sulphonamides, phenoxymethyl penicillin or phenethicillin
(2) Ampicillin Injections, Tablets and Suspensions
Urinary tract infections where sulphonamide treatment has proved ineffective and where positive bacteriological evidence shows the organism to be sensitive to ampicillin or where the patient is sensitive to sulphonamides
Broad spectrum antibiotic treatment of patients undergoing steroid therapy or recently subjected to steroid therapy
Bacterial endocarditis
Meningitis
14	Ascorbic Acid Tablets, B.P..........................................	Any disease or condition in a pensioner

15	Azathioprine....................................................................	With the written authority of the Director-General, azathioprine therapy for a person who has been discharged from an approved hospital and received that therapy while a patient in the hospital
16	Benzathine Penicillin, B.P............................................	Prophylaxis of recurrent streptococcal infections (including rheumatic fever)
17	Benzoin Compound Tincture, B.P.C. aerosol spray	Ileostomy or colostomy conditions
18	Benzylpenicillin Injection, 5,000,000 units	Bacterial endocarditis or septicaemia
19	(1) Benzylpenicillin Tablets, B.P.	Prophylaxis of recurrent streptococcal infections, (including rheumatic fever)
(2) Benzylpenicillin Capsules
20	Benzylpenicillin Injection, 10,000,000 units	Bacterial endocarditis or septicaemia
Gastrointestinal surgery
21	(1) Benzylpenicillin with Streptomycin Sulphate	Endocarditis due to streptococcus faccalis or streptococcus viridans
(2) Benzylpenicillin with Procaine Penicillin and Streptomycin Sulphate
22	Betahistine Hydrochloride............................................	Meniere’s Syndrome
23	Betamethasone Acetate and Betamethasone Injection	Intra-articular use
With the written authority of the Director-General, pre-operative and post-operative prophylactic therapy for those patients undergoing or recently subjected to steroid therapy
24	Busulphan Tablets, B.P.................................................	Treatment in malignant neoplasia
25	(1) Calciferol Tablets, Strong, B.P.	Any disease or condition in a pensioner
(2) Calciferol, B.P..........................................................	With the written authority of the Director-General—
Hypoparathyroidism
Osteomalacia following gastrectomy
Vitamin D-resistant rickets
26	Calcium Aminosalicylate.............................................	Tuberculosis
27	Capreomycin Sulphate..................................................	Tuberculosis
28	Carbamazepine..............................................................	Epilepsy
Trigeminal neuralgia
29	Carbenicillin Sodium.....................................................	With the written authority of the Director-General, infections where positive bacteriological evidence confirms that carbenicillin is the most appropriate therapeutic agent
30	Carbenoxolone Sodium................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
31	Cephaloridine ................................................................	With the written authority of the Director-General, infections where positive bacteriological evidence confirms that cephaloridine is the most appropriate therapeutic agent
32	Cephalothin Sodium.....................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
33	Ceratonia........................................................................	Oesophageal reflux in infants
34	Charcoal Tablets............................................................	Ileostomy or colostomy conditions
35	Chlorambucil Tablets, B.P...........................................	Treatment in malignant neoplasia
36	Chloramine Deodorant Tablets and	Ileostomy or colostomy conditions
Powder
37	(1) Chloramphenicol Capsules, B.P.	Bacterial meningitis
(2) Chloramphenicol Injections..................................	Intraocular infections
(3) Chloramphenicol Oral Suspension	Rickettsioses
	Typhoid
The treatment of other serious infections in a patient where it is established by appropriate bacteriological testing that Chloramphenicol is the only suitable antibiotic listed as a pharmaceutical benefit for use in treating the infection in the patient
38	Chlorotrianisene Tablets..............................................	Carcinoma of the prostate
39	(1) Chlorpromazine Hydrochloride B.P.	Any disease or condition in a patient receiving treatment in or at an approved hospital
(2) Chlorpromazine Injection, B.P.	Major psychoses including—
(3) Chlorpromazine Tablets, B.P.	Major organic psychoses
Manic psychoses
Paranoid states
Schizophrenia
40	Cholestyramine..............................................................	With the written authority of the Director-General—
Bile salt malabsorption associated with ileal resection or proven ileal disease
Pruritis associated with partial biliary obstruction not responding to other therapy
Initial treatment with cholestyramine of proven hyperbetalipoproteinaemia (type II) not responding to other therapy
A second or subsequent course of treatment for proven hyperbetalipoproteinaemia (type II) in patients who respond to treatment with cholestyramine but do not respond to other therapy
41	Clofibrate........................................................................	With the written authority of the Director-General—
Diabetic retinopathy (exudative)
Initial treatment with clofibrate of hyperlipidaemia not responding to dietary therapy
A second or subsequent course of treatment for hyperlipidaemia where significant lowering of serum cholesterol subsequent to initial treatment with clofibrate has been established by laboratory report
42	(1) Cloxacillin Sodium, B.P.........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
(2) Cloxacillin Capsules, B.P.
With the written authority of the Director-General, life threatening infection where bacteriological evidence confirms the presence of penicillinase-producing staphylococci
43	(1) Codeine Phosphate with Aspirin Soluble Tablets	Any disease or condition in a pensioner
(2) Codeine Phosphate with Aspirin Tablets
(3) Codeine Phosphate with Aspirin and Paracetamol Soluble Tablets

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whoso treatment it may be prescribed) for supply under Part VII. of the Act
43—cont.	(4) Codeine Phosphate with Aspirin and Paracetamol Tablets
(5) Codeine Phosphate with Aspirin, Paracetamol and Caffeine Tablets
44	Colistin Sulphomethate Sodium, B.P., for injection	Pyocyaneus infection, other gram-negative infections where no other drug is effective
45	Cyanocobalamin Injection, B.P...................................	Pernicious anaemia and other proven Vitamin B-12 deficiencies
Post gastrectomy treatment
Sub-acute combined degeneration of the cord
Neuroblastoma
46	(1) Cycloserine Tablets, B.P.........................................	Tuberculosis
(2) Cycloserine Capsules, B.P.
47	Cymogran........................................................................	With the written authority of the Director-General, phenylketonuria
48	(1) Cyproheptadine Hydrochloride, B.P.	Allergic rhinitis
Allergic dermatoses
(2) Cyproheptadine Tablets, B.P.	Migraine
49	Cytosine Arabinoside Hydrochloride	Any disease or condition in a patient receiving treatment in or at an approved hospital
50	Deodorant Detergent Solution (Lauryldimethyl Benzyl Ammonium Chloride and ‘TERIC’ N8)	Ileostomy or colostomy conditions
51	(1) Deoxycortone Acetate Injection, B.P.	Adrenal cortical hypofunction including Addison’s disease
(2) Deoxycortone Pivalate Injection, B.P.	Total adrenalectomy
(3) Deoxycortone Acetate Implants, B.P.
(4) Deoxycortone Acetate Tablets
52	Desferrioxamine Mesylate	Acute iron poisoning
Hepatolenticular degeneration
53	(1) Dextromoramide Tablets, B.P.	Treatment in malignant neoplasia
(2) Dextromoramide Tartrate, B.P.
54	(1) Diazepam, B.P..........................................................	Any disease or condition in a pensioner
(2) Diazepam Tablets, B.P.	Any disease or condition in a patient receiving treatment in or at an approved hospital
The treatment of a mental disorder in a patient discharged from an approved hospital at which he received treatment for a mental disorder
Epilepsy
Hereditary chorea (Huntington’s)
Malignant neoplasia (late stage)
Motor neurone lesion
Multiple sclerosis
Radiation sickness
Stiff-man syndrome
55	Dicyclomine Hydrochloride with Doxylamine Succinate and Pyridoxine Hydrochloride	Vomiting in pregnancy
56	Dienoestrol Cream.........................................................	Any disease or condition in a pensioner
57	(1) Dihydroergotoxine Mesylate Tablets	For the treatment of patients who have suffered an attack of paralytic poliomyelitis
(2) Dihydroergotoxine Mesylate Injection
58	Dihydrotachysterol	Hypoparathyroidism
59	Dimethicone Aerosol Spray.........................................	Ileostomy or colostomy conditions
60	Dimethicone Creams.....................................................	Use with surgical appliances
61	(1) Dioctyl Sodium Sulphosuccinate with Danthron	Any disease or condition in a pensioner

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
61—cont.	(2) Dioctyl Sodium Sulphosuccinate with Oxyphenisatin Acetate
62	Disodium Cromoglycate...............................................	With the written authority of the Director-General—
The prevention of attacks of asthma in the case of a patient whose attacks of asthma have been sufficiently severe and frequent to interfere seriously with his normal activities of life and whose recurrences of asthma—
(a)were not controlled by adequate use of bronchodilators and other recognized methods of prevention and treatment; or
(b)required the continuous use of corticosteroid therapy
63	Droperidol........................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
64	Ethacrynic Acid...............................................................	Fluid retention associated with heart failure, cirrhosis of the liver or nephrotic syndrome
Fluid retention associated with other conditions and not responding to thiazides
65	Ethinyloestradiol Tablets, B.P......................................	Any disease or condition in a pensioner
Carcinoma of the breast post-menopausal
Carcinoma of the prostate
Hereditary telangiectasis
Premature menopause that is surgically induced
Turner’s syndrome
66	Ethionamide....................................................................	Tuberculosis
67	Ethisterone Tablets, B.P................................................	Turner’s syndrome
68	Ethyloestrenol.................................................................	With the written authority of the Director-General—
Intermittent use for corticosteroid-induced osteoporosis
Intermittent use for patients on long-term treatment with corticosteroids
Osteomalacia following gastrectomy
69	Fludrocortisone Tablets, B.P........................................	Adrenal cortical hypoplasia including Addison’s disease
Total adrenalectomy
70	Fluorouracil Sodium......................................................	Treatment in malignant neoplasia
71	Fluoxymesterone Tablets, B.P......................................	Eunuchism
Eunuchoidism
Carcinoma of the breast
With the written authority of the Director-General—
Intermittent use for corticosteroid-induced osteoporosis
Proven aplastic anaemias
72	(1) Fluphenazine Hydrochloride, B.P.	Any disease or condition in a patient receiving treatment in or at an approved hospital
(2) Fluphenazine Tablets, B.P......................................	Major psychoses including—
(3) Fluphenazine Enanthate	Major organic psychoses
Manic psychoses
Paranoid states
Schizophrenia
73	(1) Folic Acid, B.P..........................................................	Cystic fibrosis
Proven folic acid deficiency
(2) Folic Acid Tablets, B.P. 5 mg.	Sprue or the sprue-like syndrome
74	Folic Acid Tablets, B.P. 0.5 mg.	Cystic fibrosis
Pregnancy
75	Framycetin Sulphate Tablets........................................	Bowel sterilization preparatory to major surgery
76	Frusemide Tablets, B.P..................................................	Fluid retention associated with heart failure, cirrhosis of the liver or nephrotic syndrome
Fluid retention associated with other conditions and not responding to thiazides

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
77	Galactomin Formula No. 17.........................................	With the written authority of the Director-General—
Galactosaemia
Conditions needing an extreme restriction of lactose in the diet of a patient under the age of four years
78	Galactomin Formula No. 19.........................................	With the written authority of the Director-General, glucose-galactose malabsorption
79	Gentamicin Sulphate.....................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
80	Glucose Indicator—Blood............................................	With the written authority of the Director-General, diabetes mellitus, where blood sugar levels cannot be determined to be within a satisfactory range by urine testing
81	Goat’s Milk, Dehydrated..............................................	With the written authority of the Director-General, cow’s milk allergy in children under the age of four years
82	Goat’s Milk, Whole (Sterilized)...................................	With the written authority of the Director-General, cow’s milk allergy in children under the age of four years
83	(1) Griseofulvin, B P......................................................	With the written authority of the Director-General,
(2) Griseofulvin Tablets, B.P........................................	for use in severe tinea infections due to Microsporum, Trichophyton or Epidermophyton species which have been proven by laboratory examination or Wood’s Light
84	Halibut Liver Oil Capsules...........................................	Any disease or condition in a pensioner
85	Haloperidol......................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Major psychoses including—
Major organic psychoses
Manic psychoses
Paranoid states
Schizophrenia
86	Hydrocortisone Acetate Injection, B.P.	Intra-articular use
87	Hydrocortisone Sodium Succinate Injection	Acute adrenal cortical hypofunction due to medical or surgical crisis
Prophylactic therapy before, during and after surgical procedures for patients undergoing or recently subjected to steroid therapy
88	Hydroxocobalamin Injection, B.P.	Pernicious anaemia and other proven Vitamin B-12 deficiencies
Post gastrectomy treatment
Sub-acute combined degeneration of the cord
Neuroblastoma
89	Hydroxyprogesterone Caproate ..................................	Carcinoma of the endometrium
Progesterone deficiency proved by hormonal assay, by lateral wall smear or by endometrial biopsy
90	Idoxuridine......................................................................	Infections caused by Herpes Simplex Virus
91	Influenza Vaccine..........................................................	For prophylaxis of pensioners only
92	Insect Allergen Extract—Honey Bee	With the written authority of the Director-General, service constitutional reaction to bee stings
93	Insect Allergen Extract—Jumper Ant	With the written authority of the Director-General, severe constitutional reaction to jumper ant stings
94	Insect Allergen Extract—Paper Wasp	With the written authority of the Director-General, severe constitutional reaction to wasp stings
95	Isoniazid Tablets, B P....................................................	Tuberculosis
96	Isoprenaline Hydrochloride Tablets, 30 mg.	Stokes-Adams Syndrome
97	Kanamycin Sulphate Capsules, Injections and Oral Solution	With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Kanamycin Sulphate is the most appropriate antibiotic
98	Leucovorin.......................................................................	Antidote to folic acid antagonists

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
99	Levodopa........................................................................	With the written authority of the Director-General, treatment of Parkinson’s disease
100	Levorphanol Tartrate....................................................	Obstetrical use
Severe intractable pain
101	Lignocaine Injection, B.P.............................................	Cardiac arrhythmias
102	Lincomycin Hydrochloride..........................................	Gram positive coccal infections where those cannot be safely and effectively treated with a penicillin
Osteomyelitis
103	Liothyronine Tablets, B.P.............................................	Myxoedema
104	Lofenalac........................................................................	With the written authority of the Director-General, phenylketonuria
105	Lypressin Nasal Spray..................................................	Diabetes insipidus
106	Maphenide Acetate.......................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
107	Medroxyprogesterone Acetate Tablets, 2 5 mg.	Carcinoma of the endometrium
108	Medroxyprogesterone Acetate Tablets, 10 mg.	Carcinoma of the endometrium
Precocious puberty
109	Medroxyprogesterone Acetate Tablets, 100 mg.	Carcinoma of the breast
Carcinoma of the endometrium
Hypernephroma
110	Medroxyprogesterone Acetate	Carcinoma of the endometrium
Injections	Hypernephroma
Progesterone deficiency proven by hormonal assay, by lateral wall smear or by endometrial biopsy
111	Melphalan.......................................................................	Treatment in malignant neoplasia
112	Mercaptopurine Tablets, B.P.......................................

Allergic granulomatous angiitis
Lupus erythematosus
Nephrotic syndrome
Periarteritis (Nodosa)
Treatment in malignant neoplasia
113	(1) Methandienone Tablets, B P.	With the written authority of the Director-General—
(2) Methenolone Acetate	Intermittent use for corticosteroids-induced osteoporosis
Intermittent use for patients on long-term treatment with corticosteroids
114	Methicillin Sodium, B.P. for Injection	Proven or suspected staphylococcal septicaemia
115	Methotrexate Tablets....................................................	Treatment in malignant neoplasia
116	Methotrexate Injections...............................................	Treatment in malignant neoplasia
117	Methylprednisolone Acetate........................................	With the written authority of the Director-General—
Retention Enema...........................................................	Colitis, ulcerative, proven by sigmoidoscopy or radiological report
Proctitis, proven by sigmoidoscopy
118	Methylprednisolone Acetate Injection	Intra-articular use
119	(1) Methyltestosterone Tablets, B.P.	Carcinoma of the breast
Eunuchism
(2) Methyltestosterone, B.P..........................................	Eunuchoidism
Klinefelter’s syndrome (seminiferous tubule dysgenesis)
120	Methysergide Maleate..................................................	Treatment of severe recalcitrant migraine where other treatment has failed
121	Metyrapone....................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
122	Minafen...........................................................................	With the written authority of the Director-General, phenylketonuria
123	Minocycline Hydrochloride.........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
124	Morphine Sulphate, B.P. with Tacrine Tablets	Severe intractable pain
125	Mustine Hydrochloride Injection	Treatment in malignant neoplasia

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
126	Nalidixic Acid................................................................	Urinary tract infections where sulphonamide treatment has proved ineffective and where positive bacteriological evidence shows the organism to be sensitive to nalidixic acid or where the patient is sensitive to sulphonamides
127	Nandrolone Decanoate................................................	Carcinoma of the breast
With the written authority of the Director-General—
Intermittent use for corticosteroid-induced osteoporosis
Intermittent use for patients on long-term treatment with corticosteroids
Severe osteoporosis due to proven pancreatitis
128	Nandrolone Hexoxyphenyl Propionate	Carcinoma of the breast
With the written authority of the Director-General—
Intermittent use for corticosteroid-induced osteoporosis
Intermittent use for patients on long-term treatment with corticosteroids
129	Nandrolone Phenylpropionate Injection, B.P.	Carcinoma of the breast
With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
130	Neomycin Sulphate Powder........................................	With the written authority of the Director-General, use by inhalation in cystic fibrosis (mucoviscidosis)
131	Neomycin Tablets, B.P.	Bowel sterilization preparatory to major surgery
Encephalopathy, hepatic
Enteropathogenic E. coli infections in infants
132	Nicotinic Acid Tablets, B.P.........................................	Any disease or condition in a pensioner
133	(1) Nitrofurantoin Tablets, B.P...................................	Urinary tract infections where sulphonamide treatment has proved ineffective and where positive bacteriological evidence shows the organism to be sensitive to nitrofurantoin or where the patient is sensitive to sulphonamides
(2) Nitrofurantoin Oral Suspension
134	Nitromin..........................................................................	Treatment in malignant neoplasia
135	Norethisterone Acetate, B.P........................................	Carcinoma of the breast
136	Norethisterone Tablets, B.P........................................	Endometriosis
Metropathia haemorrhagica
Precocious puberty
137	Nutramigen....................................................................	With the written authority of the Director-General—
Cow’s milk allergy in children under the age of four years
Cystic Fibrosis (mucoviscidosis)
Galactosaemia
Lactose intolerance
138	Oxprenolol Hydrochloride Tablets	With the written authority of the Director-General—
Idiopathic hypertrophic subaortic stenosis
Right ventricular outflow tract obstruction
Dissecting aneurysm, aortic
The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents
Serious arrhythmias
Thyrotoxicosis
139	Oxprenolol Hydrochloride Injection	Idiopathic hypertrophic subaortic stenosis
Right ventricular outflow tract obstruction Dissecting aneurysm, aortic
The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
139—cont.	angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents
Serious arrhythmias
Thyrotoxicosis
140	Oxycodone Pectinate....................................................	Treatment in malignant neoplasia
141	Oxymetholone................................................................	With the written authority of the Director-General—
Proven aplastic anaemias
Myelosclerosis
142	(1) Pancreatin, B.P.........................................................	Cystic Fibrosis (mucoviscidosis)
(2) Pancreatin Enzyme 4 X U.S.N.F. XII	Following pancreatico-duodenectomy
(3) Pancrelipase	Pancreatic steatorrhoea
143	(1) Paracetamol Mixture ..............................................	Any disease or condition in a pensioner
(2) Paracetamol Tablets, B.P.
144	Paracetamol with Codeine Phosphate and Pentobarbitone Sodium	Any disease or condition in a pensioner
145	(1) Paraffin Liquid Emulsion.......................................	Any disease or condition in a pensioner
(2) Paraffin Liquid Emulsion with Phenolphthalein
146	Penicillamine...................................................................	With the written authority of the Director-General—
Acute heavy metal intoxication
Cystinosis
Cystinuria with calculus formation
Haemoglobinuria, paroxysmal cold
Wilson’s disease (hepatolenticular degeneration)
147	(1) Pericyazine Mesylate..............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital;
(2) Pericyazine
Major psychoses including—
Major organic psychoses
Manic psychoses
Paranoid states
Schizophrenia
148	Phytomenadione Injection, 10 mg. per ml.	Antidote to anticoagulants
Haemorrhagic diathesis associated with malabsorption
149	Phytomenadione Injection, B.P., 1 mg. in 1 ml.	Antidote to anticoagulants
Suspected cerebral trauma of the new born Haemorrhagic diathesis associated with malabsorption
Haemorrhagic disease of the new born
150	Pituitary, Posterior Lobe, Insufflation	Diabetes insipidus
151	Plasma Substitute (Polypeptide)..................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
153	Polyisobutylene..............................................................	Ileostomy or colostomy conditions
152	Polymyxin B. Sulphate Powder...................................	With the written authority of the Director-General, use by inhalation in cystic fibrosis (mucoviscidosis)
154	Polyoestradiol Phosphate.............................................	Carcinoma of the breast
Carcinoma of the prostate
155	Practolol Injection.........................................................	Dissecting aneurysm, aortic
Idiopathic hypertrophic subaortic stenosis
Right ventricular outflow tract obstruction
Serious arrhythmias
Thyrotoxicosis
The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents.
156	Practolol Tablets............................................................	With the written authority of the Director-General—
Dissecting aneurysm, aortic

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
156—cont.	Idiopathic hypertrophic subaortic stenosis
	Right ventricular outflow tract obstruction
Serious arrhythmias
Thyrotoxicosis
The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents
157	Prednisolone Sodium Phosphate Retention Enema find Suppository	With the written authority of the Director-General—
Ulcerative colitis proven by sigmoidoscopy or radiological report
Proctitis proven by sigmoidoscopy
158	(1) Prednisolone Acetate Injection	Intra-articular use
(2) Prednisolone Butyl Acetate Injection
159	Prednisolone Sodium Succinate Injection	Acute adrenal cortical hypofunction due to any medical or surgical crisis
Prophylactic therapy before, during and after surgical procedures for patients undergoing or recently subject to steroid therapy
160	Procarbazine Hydrochloride.........................................	Treatment in malignant neoplasia
161	(1) Prochlorperazine......................................................	Meniere’s Syndrome
(2) Prochlorperazine Tablets, B.P.
162	Progesterone....................................................................	Progesterone deficiency proven by hormonal assay, by lateral wall smear or by endometrial biopsy
163	Promethazine Theoclate Tablets, B.P.	Vomiting in pregnancy
164	Propranolol Injection, B.P.	Idiopathic hypertrophic subaortic stenosis
Right ventricular outflow tract obstruction
Dissecting aneurysm, aortic
The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents
Serious arrhythmias
Thyrotoxicosis
165	Propranolol Tablets, B.P...............................................	With the written authority of the Director-General—
Idiopathic hypertrophic subaortic stenosis
Right ventricular outflow tract obstruction
Dissecting aneurysm, aortic
The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whoso attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents
Serious arrhythmias
Thyrotoxicosis
166	Proscillaridin....................................................................	Patients intolerant of oral forms of prepared digitalis, digoxin and lanatoside C
167	Prosobee...........................................................................	With the written authority of the Director-General—
Galactosaemia
Homocystinuria
Lactose intolerance
Milk allergy in children under the age of four years
168	Pyrazinamide	Any disease or condition in a patient receiving treatment in or at an approved hospital
169	(1) Pyridostigmine Injection, B.P.	Myasthenia gravis
(2) Pyridostigmine Tablets, B.P.

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
170	Pyridoxine Hydrochloride Tablets	Homocystinuria
Radiation sickness
Treatment and prophylaxis of peripheral neuritis caused or likely to be caused by isoniazid therapy
Sideroblastic (refractory anaemia)
Proven pyridoxine responsive anaemia
With the written authority of the Director-General, primary hyperoxaluria
171	Riboflavine Tablets.......................................................	Any disease or condition in a pensioner
172	Senna Fruit Extract (standardised)	Any disease or condition in a pensioner
173	Similac Isomil.................................................................	With the written authority of the Director-General—
Galactosaemia
Homocystinuria
Lactose intolerance
Milk allergy in children under the age of four years
174	Sobee	With the written authority of the Director-General—
Galactosaemia
Homocystinuria
Lactose intolerance
Milk allergy in children under the age of four years
175	(1) Sodium Aminosalicylate Tablets, B.P.	Tuberculosis
(2) Sodium Aminosalicylate Injection
(3) Sodium Aminosalicylate Cachets
(4) Sodium Aminosalicylate Granules
(5) Sodium Aminosalicylate with
Isoniazid, B.P.
176	Sodium Folate................................................................	Proven folic acid deficiency
Sprue or the sprue-like syndrome
177	(1) Sodium Fusidate......................................................	With the written authority of the Director-General,
(2) Diethanolamine Fusidate	the treatment of serious staphylococcal infections in a patient where it is established by appropriate bacteriological testing that Sodium Fusidate or Diethanolamine Fusidate in combination with another antibiotic is an appropriate therapy
178	Soyalac............................................................................	With the written authority of the Director-General—
Galactosaemia
Homocystinuria
Lactose intolerance
Milk allergy in children under the age of four years
179	Spironolactone Tablets, B.P.........................................	With the written authority of the Director-General—
To supplement other diuretics when these have proved inadequate
Myasthenia gravis
Primary hyperaldosteronism
180	Stanolone........................................................................	Carcinoma of the breast
With the written authority of the Director-General—
Intermittent use for corticosteroid-induced osteoporosis
Intermittent use for patients on long-term treatment with corticosteroids
181	Stanozolol.......................................................................	With the written authority of the Director-General—
Intermittent use for corticosteroid-induced osteoporosis
Intermittent use for patients on a long-term treatment with corticosteroids
182	Stilboestrol Diphosphate..............................................	Carcinoma of the prostate
183	Streptokinase..................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
184	Sulphasalazine...............................................................	Ulcerative colitis

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
185	(1) Surgical Cement......................................................	Ileostomy or colostomy conditions
(2) Surgical Cement Solvent........................................	For use with surgical appliances
186	(1) Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate	Eunuchoidism
Eunuchism
Klinefelter’s syndrome (seminiferous tubule dysgenesis)
		(2) Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate	Carcinoma of the breast
(3) Testosterone Implants, B.P.
(4) Testosterone Enanthate
(5) Testosterone Propionate Injection, B.P.
187	Tetanus Antitoxin, B.P. (Bovine)	Patients who have previously received an injection of equine serum
188	Thiamine Hydrochloride Tablets, B.P.	Any disease or condition in a pensioner
189	Thiethylperazine Maleate Tablets	Radiation sickness
and Suppositories	Nausea resulting from cytotoxic therapy
190	(1) Thioridazine..............................................................	Any disease or condition in a patient receiving
(2) Thioridazine Tablets, B.P.	treatment in or at an approved hospital Major psychoses including—
Major organic psychoses
Manic psychoses
Paranoid states
Schizophrenia
Severe conduct disorders of children
191	Thyrotrophin...................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
192	Tragacanth, Indian (Gum Karaya)	Ileostomy or colostomy conditions
193	Tretamine........................................................................	Treatment in malignant neoplasia
194	Triacetyloleandomycin.................................................	Amoebiasis
Brucellosis
Leptospirosis
Lymphogranuloma venereum
Pneumonia due to mycoplasma pneumoniae
Pneumonia, staphylococcal
Psittacosis
Rickettsioses
Staphylococcal septicaemia
Actinomycosis, trachoma, or any bacterial or spirochaetal infections where these cannot be safely and effectively treated by sulphonamides, phenoxymethylpenicillin or phenethicillin

195	Triamcinolone Acetonide Injection	With the written authority of the Director-General, treatment of keloids
196	(1) Trifluoperazine Hydrochloride, B.P.	Any disease or condition in a patient receiving treatment in or at an approved hospital
(2) Trifluoperazine Tablets, B.P.	Major psychoses including—
Major organic psychoses
Manic psychoses
Paranoid states
Schizophrenia
197	Triglyde............................................................................	With the written authority of the Director-General, proven malabsorption
198	Trimethoprim with Sulphamethoxazole	Any disease or condition in a patient receiving treatment in or at an approved hospital
Respiratory tract infections or urinary tract infections where positive bacteriological evidence shows trimethoprim with sulphamethoxazole to be effective

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
199	(1) Vinblastine Sulphate ..	Treatment in malignant neoplasia
(2) Vineristine Sulphate
200	Vinyl Pyrrolidone and Vinyl Acetate with Benzocaine Aerosol Spray	Ileostomy or colostomy conditions
201	(1) Viomycin Sulphate .. ..	Tuberculosis
(2) Viomycin Sulphate Injection, B.P.
202	Vitamin A with Thiamine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D Tablets and Capsules	Any disease or condition in a pensioner

                            

Printed by Authority by the Government Printer of the Commonwealth of Australia